Clinical Trials · NCT07671248
Tirzepatide in the Treatment of Cannabis Use Disorder
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- McMaster University
- Enrollment
- 15
- Start date
- Aug 2026
- Locations
- 1 site, Canada
- Primary endpoint
- Tolerability of Tirzepatide-Assisted-Psychotherapy for Cannabis Use Disorder.